Similar results were also observed by Bekos et al., who compared immune cell profiles between primary ovarian tumors and metastatic sites and reported notable differences in CD8+ and PD-1+ T-cell distributions [6]. This evidence concerns the gene CD8A and ovarian neoplasm.